News
Stay up-to-date. In our news section we regularly inform you about the latest news from HWI group.
Business Forum Ruelzheim
This year's Business Forum of the municipality of Rülzheim will take place at HWI pharma services GmbH on 30th April 2019. Rülzheim plays a pioneering role in the settlement and networking of innovative companies in the Southern Palatinate.
12th medical device forum, Munich
The 12th medical device forum will take place in Munich from 19th to 20th March 2019. The aim of this year's conference is to address the most important questions and problems in the interpretation and implementation of the EU Medical Device Regulation and to offer medical device manufacturers implementation opportunities and an exchange platform.
HWI pharma services GmbH successfully passes its first FDA inspection!
The inspection was performed at HWI’s Rülzheim site on 26th and 27th November 2018 by the US Food and Drug Administration (FDA) ...
Read more … HWI pharma services GmbH successfully passes its first FDA inspection!
Extractables & Leachables Seminar: Quality Know-How
Date: 09/04/2019, Mannheim
This seminar will provide you with comprehensive know-how for the planning, execution, toxicological evaluation and quality documentation of extractables and leachables studies.
Read more … Extractables & Leachables Seminar: Quality Know-How
10-Year Anniversary of Appenweier Site
It’s HWI development GmbH’s birthday! On Friday, 16th November 2018 10 years of development at the Appenweier site were celebrated with staff and several long-standing business associates.
That’s What Winners Look Like!
Despite the elimination of the German soccer team, this did not harm the enthusiasm for betting. HWI group's employees were hanging at the edge of their seats during the matches and hoped that they had the right instinct for betting.
HWI Campus – Your Solution for Your (Re-)Entry to Business in the EU
Following the Brexit, the United Kingdom (U.K.) will become a “Third country”. From October 31th, 2019 marketing authorisation holders based in the U.K. will need to have a registered office and/or a manufactu¬ring site with a corresponding manufacturing authori¬sation in the EU/EEA. For EU batch release and pharmacovigilance activities the QP and QPPV will also have to be resident here.
Read more … HWI Campus – Your Solution for Your (Re-)Entry to Business in the EU
"Brexit" will turn U.K. into a "Third Country" from 31st October 2019"
Following the Brexit, the United Kingdom (U.K.) will become a “Third country”. From 31st October 2019 marketing authorisation holders based in the U.K. will need to have a registered office and/or a manufacturing site with a corresponding manufacturing authorisation in the EU/EEA.
Read more … "Brexit" will turn U.K. into a "Third Country" from 31st October 2019"
Contact us
Newsletter
Current vacancies
Hotline
